Volume 22, Number 2—February 2016
Research
Feasibility of Xpert Ebola Assay in Médecins Sans Frontières Ebola Program, Guinea
Figure 3
![Ebola virus cycle threshold (Ct) values for GeneXpert Ebola Assay (nucleocapsid protein [NP] and glycoprotein [GP] genes) and routine PCR (NP gene) for patient samples identified as positive for Ebola virus by Xpert Ebola Assay at Médecins Sans Frontières Donka Ebola Treatment Center, Conakry, Guinea, May–June 2015. ID, identification.](/eid/images/15-1238-F3.jpg)
Figure 3. Ebola virus cycle threshold (Ct) values for GeneXpert Ebola Assay (nucleocapsid protein [NP] and glycoprotein [GP] genes) and routine PCR (NP gene) for patient samples identified as positive for Ebola virus by Xpert Ebola Assay at Médecins Sans Frontières Donka Ebola Treatment Center, Conakry, Guinea, May–June 2015. ID, identification.
Page created: January 13, 2016
Page updated: January 13, 2016
Page reviewed: January 13, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.